Conan Laughlin decreased its stake in Gilead Sciences Inc (GILD) by 50% based on its latest 2017Q3 regulatory filing with the SEC. North Tide Capital Llc sold 500,000 shares as the company’s stock declined 8.05% while stock markets rallied. The hedge fund run by Conan Laughlin held 500,000 shares of the health care company at the end of 2017Q3, valued at $40.51M, down from 1.00M at the end of the previous reported quarter. North Tide Capital Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $105.78B market cap company. The stock decreased 0.53% or $0.43 during the last trading session, reaching $80.98. About 4.89 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 23, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.
Kemnay Advisory Services Inc increased its stake in Alibaba Group Hldg Ltd (BABA) by 57.44% based on its latest 2017Q3 regulatory filing with the SEC. Kemnay Advisory Services Inc bought 29,184 shares as the company’s stock rose 22.58% with the market. The institutional investor held 79,995 shares of the business services company at the end of 2017Q3, valued at $13.82M, up from 50,811 at the end of the previous reported quarter. Kemnay Advisory Services Inc who had been investing in Alibaba Group Hldg Ltd for a number of months, seems to be bullish on the $490.80 billion market cap company. The stock increased 3.95% or $7.2645 during the last trading session, reaching $191.2845. About 25.15 million shares traded or 27.97% up from the average. Alibaba Group Holding Limited (NYSE:BABA) has risen 57.33% since January 23, 2017 and is uptrending. It has outperformed by 40.63% the S&P500.
Among 37 analysts covering Alibaba (NYSE:BABA), 35 have Buy rating, 1 Sell and 1 Hold. Therefore 95% are positive. Alibaba had 158 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of Alibaba Group Holding Limited (NYSE:BABA) has “Overweight” rating given on Tuesday, June 27 by JP Morgan. The stock has “Overweight” rating by Barclays Capital on Wednesday, March 29. As per Thursday, October 19, the company rating was maintained by KeyBanc Capital Markets. The rating was maintained by Wedbush with “Neutral” on Friday, January 29. The firm earned “Buy” rating on Monday, April 25 by Deutsche Bank. Oppenheimer maintained Alibaba Group Holding Limited (NYSE:BABA) on Tuesday, August 22 with “Buy” rating. As per Thursday, December 8, the company rating was reinitiated by Morgan Stanley. The rating was maintained by Credit Suisse on Friday, May 6 with “Outperform”. The firm has “Buy” rating by SunTrust given on Friday, August 12. On Monday, June 12 the stock rating was maintained by Jefferies with “Buy”.
Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 112 analyst reports since July 29, 2015 according to SRatingsIntel. Credit Suisse initiated the stock with “Outperform” rating in Wednesday, January 20 report. Stifel Nicolaus initiated Gilead Sciences, Inc. (NASDAQ:GILD) rating on Monday, November 14. Stifel Nicolaus has “Buy” rating and $100 target. The firm earned “Strong Buy” rating on Thursday, September 10 by Jyske Bank. Mizuho maintained it with “Buy” rating and $7700 target in Tuesday, July 25 report. The stock has “Buy” rating by Maxim Group on Thursday, November 30. Credit Suisse maintained the shares of GILD in report on Monday, August 28 with “Buy” rating. The firm earned “Outperform” rating on Wednesday, March 23 by Credit Suisse. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Market Perform” rating given on Thursday, October 19 by Leerink Swann. The company was initiated on Thursday, February 11 by Oppenheimer. Bank of America maintained the stock with “Neutral” rating in Wednesday, October 4 report.
Since August 1, 2017, it had 0 buys, and 13 selling transactions for $51.52 million activity. Alton Gregg H sold 15,000 shares worth $1.14M. Another trade for 51,820 shares valued at $4.40 million was made by Washington Robin L on Thursday, September 7. 100,000 shares were sold by Meyers James R, worth $8.02M.
Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 earnings per share, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18 billion for 12.12 P/E if the $1.67 EPS becomes a reality. After $2.23 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.
North Tide Capital Llc, which manages about $2.06B and $468.88M US Long portfolio, upped its stake in Mckesson Corp (NYSE:MCK) by 350,000 shares to 500,000 shares, valued at $76.81M in 2017Q3, according to the filing.
Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It improved, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Hm Payson & accumulated 115,608 shares. New England Rech & Mgmt Incorporated reported 1.1% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Ameriprise owns 0.21% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 5.51 million shares. First Commonwealth Corporation Pa holds 1.14% or 12,372 shares. 42,267 are held by Cantab Cap Prtnrs Ltd Liability Partnership. Meridian Investment Counsel has invested 0.92% in Gilead Sciences, Inc. (NASDAQ:GILD). Fairfield Bush has 0.14% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Cap Int Sarl holds 41,850 shares or 0.28% of its portfolio. Aviva Public Ltd Co invested 0.41% in Gilead Sciences, Inc. (NASDAQ:GILD). The New Jersey-based Landscape Cap Management Ltd Company has invested 0.04% in Gilead Sciences, Inc. (NASDAQ:GILD). Greylin Investment Mangement holds 0.48% or 25,777 shares in its portfolio. Mason Street Advisors Lc reported 181,287 shares. Ajo Lp holds 0.52% or 1.48 million shares in its portfolio. Raymond James Finance Advsr holds 283,393 shares or 0.15% of its portfolio. Invesco Ltd holds 17.81 million shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.